Zobrazeno 1 - 10
of 12
pro vyhledávání: '"C W, Hendrix"'
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 3, Iss 11, Pp 1-6 (2014)
Empirical pharmacokinetic models are used to explain the pharmacokinetics of the antiviral drug tenofovir (TFV) and its metabolite TFV diphosphate (TFV‐DP) in peripheral blood mononuclear cells. These empirical models lack the ability to explain di
Externí odkaz:
https://doaj.org/article/2f8860edbdf1471f962898a1416db6a3
Publikováno v:
The Journal of Immunology. 153:862-872
In vitro activation of PBLs from HIV+ individuals resulted in programmed cell death (PCD) within 2 days in 58 of 95 HIV+ blood donors, in contrast to only two of 30 control HIV- donors. CD4+ and CD8+ T cells from HIV+ donors died under these conditio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6afa695096fdacdec5f21abb15928d63
https://doi.org/10.4049/jimmunol.153.2.862
https://doi.org/10.4049/jimmunol.153.2.862
Autor:
C W, Hendrix, F D, Daniell
Publikováno v:
AIDSpublic policy journal. 14(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f77378a6ce4df246f1cbd8702afa9d2
https://pubmed.ncbi.nlm.nih.gov/10915288
https://pubmed.ncbi.nlm.nih.gov/10915288
Publikováno v:
Military medicine. 165(2)
A survey was conducted to evaluate military human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) policies and programs in 119 countries. Ninety-eight percent of the 62 respondents provide prevention education, 95% in group setti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::266db63d1e3f79e34a3e12fc2685a7f3
https://pubmed.ncbi.nlm.nih.gov/10709366
https://pubmed.ncbi.nlm.nih.gov/10709366
Autor:
L I, Gardner, S H, Harrison, C W, Hendrix, S P, Blatt, K F, Wagner, R C, Chung, R W, Harris, D L, Cohn, D S, Burke, D L, Mayers
Publikováno v:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 17(4)
The study's objectives were to determine the size and duration of benefits of early versus delayed versus late treatment with zidovudine (ZDV) on disease progression and mortality in HIV-infected patients, and whether patients rapidly progressing bef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9456b9e3f197abd8aa3dbcf7b94e1da5
https://pubmed.ncbi.nlm.nih.gov/9525436
https://pubmed.ncbi.nlm.nih.gov/9525436
Publikováno v:
Antimicrobial agents and chemotherapy. 41(8)
This phase I, double-blind, randomized, placebo-controlled, parallel-design study was conducted to evaluate the safety and pharmacokinetics of levofloxacin in human immunodeficiency virus (HIV)-infected subjects concomitantly receiving a stable regim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae12a582c697c90ed6af96926261c243
https://pubmed.ncbi.nlm.nih.gov/9257757
https://pubmed.ncbi.nlm.nih.gov/9257757
Autor:
J M, Musser, V, Kapur, J E, Peters, C W, Hendrix, D, Drehner, G D, Gackstetter, D R, Skalka, P L, Fort, J T, Maffei, L L, Li
Publikováno v:
Archives of pathologylaboratory medicine. 118(2)
To determine if molecular epidemiologic techniques, including comparative automated DNA sequencing of polymorphic virulence genes, could be used in the course of a bacterial disease outbreak to unambiguously determine clonal relationships among impli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5c054855abd1d50e8b3da2d3e24e8280
https://pubmed.ncbi.nlm.nih.gov/8311650
https://pubmed.ncbi.nlm.nih.gov/8311650
Autor:
D R, Lucey, T C, VanCott, L D, Loomis, F R, Bethke, C W, Hendrix, G P, Melcher, R R, Redfield, D L, Birx
Publikováno v:
Journal of acquired immune deficiency syndromes. 6(9)
Antibody to the human immunodeficiency virus (HIV)-1 principal neutralizing determinant (V3 loop) was measured by peptide enzyme-linked immunosorbent assay (ELISA) in cerebrospinal fluid (CSF) and paired serum samples of 21 HIV-seropositive patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::15d7dbf04cf344feafda0705f730e618
https://pubmed.ncbi.nlm.nih.gov/7688046
https://pubmed.ncbi.nlm.nih.gov/7688046
Publikováno v:
JAMA. 269(5)
To determine whether the total lymphocyte count (TLC) accurately predicts a low absolute CD4+ T-cell count and CD4+ percentage in persons infected with human immunodeficiency virus (HIV).Retrospective analysis of data collected in the US Air Force HI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d28a8ad27ec52d4a2aa6dc1e9edeabc3
https://pubmed.ncbi.nlm.nih.gov/8093628
https://pubmed.ncbi.nlm.nih.gov/8093628
Autor:
D R, Lucey, C W, Hendrix, C, Andrzejewski, G P, Melcher, C A, Butzin, R, Henry, F H, Wians, R N, Boswell
Publikováno v:
Journal of acquired immune deficiency syndromes. 5(4)
European patients with human immunodeficiency virus type 1 (HIV-1) infection have been reported to have lower titers of anti-p24 antibody than Central African HIV seropositive patients. Recently, black HIV positive patients in the United States were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d702a3635d1a48bfd956fde18bcf6e0e
https://pubmed.ncbi.nlm.nih.gov/1347787
https://pubmed.ncbi.nlm.nih.gov/1347787